Senators Chris Van Hollen and Rick Scott Offer Approach to Ensure Innovation & Access to Taxpayer-Funded Drugs.
Legislation would bring relief to seniors through much-needed Part D overhaul. Key provision would restrain excessive annual price hikes by Big Pharma. CBO: Bill to save beneficiaries and taxpayers $117 billion in a decade.
Massachusetts drug pricing model paves the way for states and nation.
Grandmother living with diabetes, asthma to tell committee: “Drugs don’t work if people can’t afford them”
If drug corporations want to gouge patients, the public deserves to know exactly why.
This is a victory for Maine patients and taxpayers who are fed up with unrestrained drug prices.
Don’t be fooled by Big Pharma’s spin. There is no evidence the proposed Part B changes would impact patient access to drugs.
After Mainers speak out, slate of drug pricing reforms gains momentum.
The legislation sets a model for the nation to make prescription drugs more affordable.
Measure would outlaw deals that block generic prescription drugs.
Drug corporations have run amok — abusing our patent system and leaving Americans bankrupt and sick.
As Pennsylvania state lawmakers weigh key measures to protect residents from Big Pharma’s skyrocketing drug prices, patients are calling for reform.
Read David Mitchell’s testimony covering his battle against multiple myeloma and imploring Congress to help patients.
We are encouraged by continued Congressional action to address an array of abusive tactics Big Pharma uses to block competition and keep drug prices high.
Today’s congressional briefing featured a bipartisan panel of experts who agreed that International Reference Pricing can lower drug prices in the U.S. while maintaining innovation.
Patients are turning up at statehouses to tell lawmakers just how harmful high drug prices have become — their voices are seeding a movement.
Patient testimony to call for urgent action in Augusta to lower drug prices.
Hearings, new legislation, and committee passage mark a productive week for drug pricing.
Patient testimony to call for urgent action to lower drug prices.
Patients appreciate Chairman Neal, Ranking Member Brady, and members on both sides of the aisle for working on an issue that is sending far too many Americans into debt.